ArticleBMC public health2025
Cancer screening and its associated factors in hypertensive individuals: new insights from the 2021 STEPs national study in Iran.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Gastric Cancer Literacy and Related Factors in Iran: A Cross-Sectional Study.Cancer reports (Hoboken, N.J.) · 2026Article
- Association between polypharmacy and hypertension in the Iranian population aged 50 years or older: Iranian Multicenter Osteoporosis Study (IMOS-2021).BMC primary care · 2025Article
- Why do middle-aged adults use or avoid health services? A study of social and demographic determinants.Journal of preventive medicine and hygiene · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundCancer continues to be a major cause of death worldwide with almost 10 million deaths from cancer each year and a significant financial burden on healthcare systems. Hypertension can increase the risk of developing certain cancers and their complications, necessitating higher screening rates in the hypertensive population. Although screening for cancer can reduce mortality rates and help with early diagnosis, the screening rates in Iran are far below the optimal level. This study aimed to identify factors associated with cancer screening participation among hypertensive individuals.
methodsWe utilized data from the STEPs 2021 survey, a large-scale nation-wide cross-sectional study conducted in Iran to assess non-communicable disease (NCD) risk factors. The survey followed the WHO's STEPwise approach and included adults aged 18 and older from both urban and rural areas of 31 provinces of Iran. The effect of each covariate on different types of cancer screening was determined using odds ratios (ORs) which were estimated using univariate and multivariate logistic regression models.
resultsWe found that screening rates were significantly influenced by age, marital status, employment, wealth, and residential area. Middle-aged women were more likely to participate in breast and cervical cancer screenings, whereas prostate cancer screening was more common among men aged 70 and older. Furthermore, awareness and control of hypertension, a history of cancer, comorbid chronic diseases, and receiving lifestyle advice were all associated with increased screening participation. Lifestyle scores, BMI, education level, and insurance coverage were all linked to higher screening rates for most cancer types.
conclusionDespite these findings, cancer screening rates in Iran remain alarmingly low, particularly among high-risk groups such as hypertensive individuals. Urgent reforms and targeted strategies are required to increase screening uptake and enhance early detection efforts in populations at risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.